[Optimization of the treatment of patients with chronic cardiac insufficiency and cardiopulmonary pathology].
Evdokimova
A G
AG
Radzevich
A E
AE
Kovalenko
E V
EV
Klevtsova
N Iu
NIu
Zolotareva
E V
EV
Evdokimov
V V
VV
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001578:Benzopyrans / Q000008:administration & dosage; D002301:Cardiac Glycosides / Q000008:administration & dosage; D004656:Enalapril / Q000008:administration & dosage; D004983:Ethanolamines / Q000008:administration & dosage; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006331:Heart Diseases / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000068577:Nebivolol; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology*
D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D001578:Benzopyrans; D002301:Cardiac Glycosides; D004983:Ethanolamines; D005938:Glucocorticoids; D000068577:Nebivolol; D004656:Enalapril